Multiple high dose tDCS sessions produces perceived improvement and stabilisation in a person with a MAPT gene, presenting clinically as semantic variant primary progressive aphasia with severe cognitive impairment

• C. Roncero,
• A. Popov,
• H. Chertkow

Affiliations

C. Roncero

Corresponding author.; Baycrest Health Sciences, Rotman Research Institute, Toronto, Ontario, Canada

A. Popov

Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec, Canada

H. Chertkow

Corresponding author.; Baycrest Health Sciences, Rotman Research Institute, Toronto, Ontario, Canada